ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,204.89
0.21%
Dow Jones
40,665.02
-1.29%
Gold vs US Dollar
2,423.24
-0.90%
Brent Oil
83.835
-0.29%
Bitcoin
64,128.78
0.25%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Amylyx Pharmaceuticals Inc (AMLX) Share Price

AMLX Amylyx Pharmaceuticals Inc

2.00
-0.12 (-5.66%)
19 Jul 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Amylyx Pharmaceuticals Inc NASDAQ:AMLX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.12 -5.66 2.00 2.01 2.14 2.18 2.00 2.13 1,340,711 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 380.79M 49.27M 0.7245 2.76 144.17M
 Type  Size  Price  Time  Units 
 9 1 2.01 23:52:21 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore AMLX News
19/07/202400:00PRNUSKuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm
10/07/202412:09EDGAR2Form 8-K - Current report
10/07/202412:00BWAmylyx Pharmaceuticals Announces Acquisition of Phase 3-ready GLP-1 Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation
09/07/202421:01BWAmylyx Pharmaceuticals to Host Conference Call to Discuss the Acquisition of Avexitide
07/06/202421:52EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
07/06/202421:50EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
07/06/202421:49EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
Period
Draw mode
Data Downloads for AMLX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Amylyx Pharmaceuticals Inc Articles